16:29 , Aug 18, 2017 |  BC Week In Review  |  Financial News

Drug delivery play Intec raises $50M

On Aug. 16, Intec Pharma Ltd. (Tel Aviv; NASDAQ:NTEC) raised $50 million through the sale of 10.6 million shares at $4.70 in a follow-on underwritten by Oppenheimer, Roght Capital Partners and Maxim Group. Intec expects...
22:32 , Aug 16, 2017 |  BC Extra  |  Financial News

Drug delivery play Intec raises $50M

Intec Pharma Ltd. (Tel Aviv:NTEC; NASDAQ:NTEC) jumped $0.65 (13%) to $5.50 on NASDAQ after raising $50 million through the sale of 10.6 million shares at $4.70 in a follow-on underwritten by Oppenheimer, Roth Capital Partners...
20:16 , Mar 24, 2017 |  BC Week In Review  |  Clinical News

AP-CBD/THC: Ph I started

Intec began a 3-way crossover, Israeli Phase I trial to evaluate 2 formulations of AP-CBD/THC compared to sublingual cannabis extract spray Sativex nabiximols in 21 healthy volunteers. Intec Pharma Ltd. (Tel Aviv:NTEC; NASDAQ:NTEC), Jerusalem, Israel ...